ICU Admission
3
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Active Glycemic Control Strict 80140mgdl Vs Conservative 190220mgdl With Or Without Continuous Glucose Monitoring
Research Leaders
10 sponsors active, led by Monash University
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
33%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
PrognostICate- Study:Prognostication of ICU- and Ventilator- Days Over the Next Years Until 2040
Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)
Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial
Research Network
Common Treatments
- Active Glycemic Control Strict 80140mgdl Vs Conservative 190220mgdl With Or Without Continuous Glucose Monitoring1
- Osmolite1
- Nutraflora Scfos1
- Intensive Care Unit Icu Treatment1
Active Sponsors
- Monash University1
- Johann Wolfgang Goethe University Hospital1
- Albert Einstein College of Medicine1
- The Alfred1
- Indiana University1
Top Investigators
Emory University and Children's Healthcare of Atlanta at Egleston
Duke University
Related Conditions
- Pediatric Patient 1m21y1
- Enteral Nutrition1
- Brain Injuries Traumatic1
- Hyperglycemia1